Healius Limited

A$0.50As of Sun 8 Nov 2026, 12:00 UTC
ASX:HLSHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (13.52%)
Div yield —
ROE (107.69%)
Diagnostics & Research
Beta (5Y) 0.28
PE TTM —
TSR TTM (43.82%)
Mkt cap A$363.1M
ROIC 2.37%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.575
14.98%
(83.50%)
Hold 8|3|2|6|11
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.01
0.01
0.01
0.01
(3.63%)
0.62%
2.58%
5.02%
Revenue$M
20.36
19.91
20.27
21.33
10.56%
9.41%
7.18%
8.97%
Peers (US$249.4M)
Cap (US$)
PE
411.8M
26.28x
198.0M
38.95x
252.1M
77.04x
Capital
TTM
5Y
10Y
Leveragex
5.100
4.973
5.182
EBIT/Intx
2.316
3.027
2.908
Own earn%
84.38
(25.27)
(24.68)
Sh yield%
15.81
17.98
19.32
Owners
Insiders/Inst%
4.90
77.77
Short interest%
2.15
SBC / revenue%
0.27
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
15–19
$1 testx
—
Incr. ROIC%
4